# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031655
Filing Date
2022-11-14
Accepted
2022-11-14 08:30:36
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1106416
2 |  | ex31-1.htm | EX-31.1 | 15468
3 |  | ex31-2.htm | EX-31.2 | 15473
4 |  | ex-32.htm | EX-32 | 12746
| Complete submission text file | 0001493152-22-031655.txt |  | 5150149

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | abeo-20220930.xsd | EX-101.SCH | 32577
6 | XBRL CALCULATION FILE | abeo-20220930_cal.xml | EX-101.CAL | 65000
7 | XBRL DEFINITION FILE | abeo-20220930_def.xml | EX-101.DEF | 169354
8 | XBRL LABEL FILE | abeo-20220930_lab.xml | EX-101.LAB | 343863
9 | XBRL PRESENTATION FILE | abeo-20220930_pre.xml | EX-101.PRE | 275475
59 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 734327

Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 221380610
SIC: 2834 Pharmaceutical Preparations